Current ratings for:
Genetic Researchers Find New, Low-Cost Approach For Ovarian And Breast Cancer Testing
In a new genetic study, researchers said they may have found a way to cut the cost of genetic screening for breast and ovarian cancers from $3000 to $400.
Three teams of infertility scientists in New York and Austria collaborated to study gene mutations that increase a woman’s likelihood of breast and ovarian cancers. In the process, they made a discovery that could reduce to the cost of breast and ovarian cancer screening, making diagnosis more widely available to women in need.